New Zealand markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
44.88-0.81 (-1.77%)
At close: 04:00PM EST
44.97 +0.09 (+0.20%)
Pre-market: 08:38AM EST
Show:
Income statement
Balance sheet
Annual

Cash flow

Currency in GBP. All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
Cash flows from operating activities
Net income
4,313,000
5,749,000
4,645,000
3,623,000
Depreciation & amortisation
4,692,000
2,351,000
2,334,000
1,856,000
Stock-based compensation
-
381,000
365,000
360,000
Change in working capital
597,000
2,427,000
294,000
3,423,000
Inventory
-
119,000
300,000
51,000
Other working capital
4,896,000
6,202,000
5,857,000
6,625,000
Other non-cash items
1,267,000
1,312,000
892,000
757,000
Net cash provided by operating activities
8,040,000
8,441,000
8,020,000
8,421,000
Cash flows from investing activities
Investments in property, plant and equipment
-3,144,000
-2,239,000
-2,163,000
-1,796,000
Acquisitions, net
-302,000
-535,000
-3,953,000
-472,000
Purchases of investments
-
-1,000
-258,000
-309,000
Sales/maturities of investments
-
3,269,000
1,000
0
Net cash used for investing activities
-1,468,000
2,161,000
-5,354,000
-1,553,000
Net change in cash
-418,000
470,000
826,000
479,000
Cash at beginning of period
3,656,000
4,831,000
4,087,000
3,600,000
Cash at end of period
3,238,000
5,262,000
4,831,000
4,087,000
Free cash flow
Operating cash flow
8,040,000
8,441,000
8,020,000
8,421,000
Capital expenditure
-3,144,000
-2,239,000
-2,163,000
-1,796,000
Free cash flow
4,896,000
6,202,000
5,857,000
6,625,000